Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Sepeda VO"'
Autor:
Bowen CM; Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Deng N; Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Reyes-Uribe L; Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Parra ER; Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Rocha P; Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Solis LM; Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Wistuba II; Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Sepeda VO; Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Vornik L; Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Perloff M; Division of Cancer Prevention, National Cancer Institute, Bethesda, MD, United States., Szabo E; Division of Cancer Prevention, National Cancer Institute, Bethesda, MD, United States., Umar A; Division of Cancer Prevention, National Cancer Institute, Bethesda, MD, United States., Sinha KM; Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Brown PH; Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Vilar E; Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.; Clinical Cancer Genetics Program, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
Publikováno v:
Frontiers in immunology [Front Immunol] 2023 May 03; Vol. 14, pp. 1162669. Date of Electronic Publication: 2023 May 03 (Print Publication: 2023).
Autor:
Del Carmen G; Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.; McGovern Medical School, University of Texas Health Science Center, Houston, TX, United States., Reyes-Uribe L; Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Goyco D; Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.; Department of Medicine, Baylor College of Medicine, Houston, TX, United States., Evans K; Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Bowen CM; Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Kinnison JL; Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Sepeda VO; Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Weber DM; Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Moskowitz J; Clinical Cancer Genetics Program, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Mork ME; Clinical Cancer Genetics Program, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Thirumurthi S; Clinical Cancer Genetics Program, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.; Department of Gastroenterology, Hepatology and Nutrition, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Lynch PM; Clinical Cancer Genetics Program, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.; Department of Gastroenterology, Hepatology and Nutrition, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Rodriguez-Bigas MA; Clinical Cancer Genetics Program, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.; Department of Colorectal Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Taggart MW; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., You YN; Clinical Cancer Genetics Program, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.; Department of Colorectal Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Vilar E; Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.; Clinical Cancer Genetics Program, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
Publikováno v:
Frontiers in oncology [Front Oncol] 2023 Apr 24; Vol. 13, pp. 1146825. Date of Electronic Publication: 2023 Apr 24 (Print Publication: 2023).
Autor:
Lynch PM; Department of Gastroenterology, Hepatology & Nutrition, The University of Texas MD Anderson Cancer Center, Houston, TX 77030-4009, USA. plynch@mdanderson.org, Morris JS, Ross WA, Rodriguez-Bigas MA, Posadas J, Khalaf R, Weber DM, Sepeda VO, Levin B, Shureiqi I
Publikováno v:
Gastrointestinal endoscopy [Gastrointest Endosc] 2013 Mar; Vol. 77 (3), pp. 455-63. Date of Electronic Publication: 2013 Jan 18.